Literature DB >> 589869

The mechanism behind the effect of ALG on platelets in vivo.

A Henricsson, B Husberg, S E Bergentz.   

Abstract

Antilymphocyte globulin (ALG) and antiplatelet globulin (APG) were injected in dogs whose autologous platelets were labelled with 51Cr. APG injection resulted in almost complete and irreversible disappearance of labelled platelets. ALG produced thrombocytopenia of the same degree, but this was to a large extent reversible. After injection of ALG the platelets were reversibly trapped in the lung during the time when platelet count in peripheral blood was low. Such trapping was not seen after administration of APG. This suggests an antiplatelet mechanism of ALG quite different from that of APG. Platelet-absorbed ALG and non-platelet-absorbed ALG produced thrombocytopenia of the same degree and pattern, making it less likely that the thrombocytopenia was caused by specific platelet antibodies. Also platelet-absorbed APG induced thrombocytopenia, but this was reversible and 'ALG-like'. The mechanism behind the platelet reaction after an ALG injection is well explained in terms of complement C3 adherence and/or Fc receptor-induced aggregation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 589869      PMCID: PMC1541076     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Disk electrophoresis of basic proteins and peptides on polyacrylamide gels.

Authors:  R A REISFELD; U J LEWIS; D E WILLIAMS
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

2.  A reversible acute reaction following intravenous administration of antithymocyte globulin.

Authors:  R Perper; A Pultavituma; M Palutke; J C Rosenberg
Journal:  Int Arch Allergy Appl Immunol       Date:  1971

Review 3.  Immunologic mechanisms of platelet damage.

Authors:  A G Osler; R P Siraganian
Journal:  Prog Allergy       Date:  1972

Review 4.  The clinical use of antilymphocyte globulin.

Authors:  J S Najarian; R L Simmons
Journal:  N Engl J Med       Date:  1971-07-15       Impact factor: 91.245

5.  Controlled clinical trial of antilymphocyte globulin in patients with renal allografts from cadaver donors.

Authors:  A G Sheil; G E Kelly; B G Storey; J May; S Kalowski; D Mears; J H Rogers; J R Johnson; J Charlesworth; J H Stewart
Journal:  Lancet       Date:  1971-02-20       Impact factor: 79.321

6.  Antibody localization in horse, rabbit, and goat antilymphocyte sera.

Authors:  N Kashiwagi; D Sherer; C M Townsend; R Jacobs; K Ono; B Kapur; T E Starzl
Journal:  Surgery       Date:  1970-05       Impact factor: 3.982

7.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

8.  Immune reactions of human blood platelets. I. A comparative study on the effects on platelets of heterologous antiplatet antiserum, antigen-antibody complexes, aggregated gammaglobulin and thrombin.

Authors:  C Mueller-Eckhardt; E F Lüscher
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

9.  Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.

Authors:  D Bitter-Suermann; M Dierich; W König; U Hadding
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

10.  Platelet complement fixation: an in vitro test of the immunosuppressive activity of antilymphocyte globulin.

Authors:  I C Balfour; G D Pegrum; G B Williams; H Balner
Journal:  Transplantation       Date:  1972-09       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.